undamentalytics Newsletter
Sign in

Ironwood Pharmaceuticals Inc balance sheet

At the end of fiscal 2025, Ironwood Pharmaceuticals Inc had total assets of $397m, total liabilities of $659m and shareholders' equity of −$262m. It held $215m in cash against $585m of debt: net debt of $369m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents1224487137757426154126173177363620656928921579
Receivables—0001031321111221141151298247113
Inventory———7225—11—1———————
Total current assets—259168184229288500380312266307496745781233182274199
Goodwill———————1111———————
Total assets—3012092302793296197106063324035591,1271,101471351397285
Accounts payable—46141010918161541108231
Deferred revenue (current)—40363577———1———3211
Total current liabilities—64655541617691661204132162262763924233
Long-term debt————175158221132147101—430454396398199——
Total debt0000175169336132249313408430454413500385585385
Total liabilities————————————————659447
Shareholders' equity−2981601101443889956710−196−9363606652−346−301−262−162
Net debt (negative = net cash)−122−44−87−1379995747812314023168−166−243407296369306
Shares outstanding—————————154m158m161m162m154m156m160m163m165m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: INVA vs IRWDIRWD vs XERSEOLS vs IRWD

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Ironwood Pharmaceuticals Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ironwood Pharmaceuticals Inc.